Metropolitan Life Insurance Company (MetLife)’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-5,792
| Closed | -$73.1K | – | 2590 |
|
|
2021
Q4 | $73.1K | Buy |
5,792
+547
| +10% | +$6.9K | ﹤0.01% | 2621 |
|
|
2021
Q3 | $481K | Hold |
5,245
| – | – | 0.01% | 1495 |
|
|
2021
Q2 | $278K | Buy |
5,245
+265
| +5% | +$14K | ﹤0.01% | 1920 |
|
|
2021
Q1 | $179K | Hold |
4,980
| – | – | ﹤0.01% | 2097 |
|
|
2020
Q4 | $138K | Hold |
4,980
| – | – | ﹤0.01% | 2185 |
|
|
2020
Q3 | $249K | Hold |
4,980
| – | – | ﹤0.01% | 1647 |
|
|
2020
Q2 | $231K | Buy |
4,980
+1,161
| +30% | +$53.8K | ﹤0.01% | 1705 |
|
|
2020
Q1 | $174K | Hold |
3,819
| – | – | ﹤0.01% | 1674 |
|
|
2019
Q4 | $214K | Buy |
+3,819
| New | +$214K | ﹤0.01% | 1872 |
|